Yufei Li
State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, China
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Factors on Knowledge, Health Beliefs, and Willingness toward Human Papillomavirus Vaccine among Chinese Parents, a cross-sectional study in Ordos City, China.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort.
Journal: The Lancet regional health. Western Pacific
Published: May 01, 2025
The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort study.
Journal: International journal of cancer
Published: August 14, 2024
Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18-45 years.
Journal: Human vaccines & immunotherapeutics
Published: April 15, 2024
Evaluation of an E6/E7 PCR-capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer.
Journal: Journal of medical virology
Published: March 23, 2024
Impact of high-performance human papillomavirus testing to improve cervical cancer screening in China: a prospective population-based multicentre cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: October 24, 2023
Characteristics of human papillomavirus prevalence and infection patterns among women aged 25-64 according to age groups and cytology results in Ordos City, China.
Journal: Virology journal
Published: August 07, 2023
Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial.
Journal: Emerging microbes & infections
Published: March 06, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026